Humana Inc. (NYSE:HUM) Q3 2023 Earnings Call Transcript

Benjamin Mayo: Just one home and how much you’ve delegated the risk on that business today in terms of like the post-acute or the DME and how much of that is driving growth on your Home Solutions business?

Susan Diamond: Sure. As far as the agents, I think with some of the information we shared about the increased penetration that we’ve seen. You can think of that as about $250,000 an additional sales for agents for the full year. And then we see the incremental benefit of the margin progression on that. Like I said, it’s disproportionately weighted to year 3 by the time those members ultimately convert. In terms of one home, it’s about 15% of MA membership. I think in answer to your question.

Benjamin Mayo: Okay. But how much of like the — if I take all of your post-acute spend, how much of that have you fully rolled out in terms of the full delegation of risk?

Susan Diamond: Yes. Why don’t we — we can get back to you with a specific answer on that. Let us look at that. And when we talk late tomorrow, we can have that answer for you.

Operator: That concludes our question-and-answer session. I’d like to turn the call back to Bruce Broussard for closing remarks.

Bruce Broussard: Thank you, operator. In closing, I echo seasons, thanks to our 65,000 employees. We truly appreciate their hard work and dedication to bring each day to serve our members and patients. I’d also reiterate the thanks to our shareholders for their continued support. Managed fundamentals are strong and we remain committed to leveraging the strength and scale of our enterprise navigate near-term challenges while continuing to advance our strategy. And importantly, we remain committed to our 2025 adjusted EPS target of $37, reflecting a 14% compounded annual growth rate from 2022 to 2025. I hope everyone has a great day.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.